Brock Reeve

1.1k total citations · 1 hit paper
13 papers, 661 citations indexed

About

Brock Reeve is a scholar working on Physiology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Brock Reeve has authored 13 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Molecular Biology and 6 papers in Biomedical Engineering. Recurrent topics in Brock Reeve's work include Biomedical Ethics and Regulation (9 papers), Pluripotent Stem Cells Research (7 papers) and Biomedical and Engineering Education (3 papers). Brock Reeve is often cited by papers focused on Biomedical Ethics and Regulation (9 papers), Pluripotent Stem Cells Research (7 papers) and Biomedical and Engineering Education (3 papers). Brock Reeve collaborates with scholars based in United States, United Kingdom and Germany. Brock Reeve's co-authors include Jeffrey M. Karp, Deepak Bhere, Erika M. J. Siren, Rui Kuai, Reza Abdi, Ali H. Alhasan, Oren Levy, Abdulaziz Almalik, Khalid Shah and Yuka Milton and has published in prestigious journals such as Nature Biotechnology, Cell stem cell and Science Advances.

In The Last Decade

Brock Reeve

13 papers receiving 651 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Shattering barriers toward clinically meaningful MSC therapies

2020 447 citations Oren Levy, Rui Kuai et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brock Reeve United States	10	307	302	194	116	95	13	661
Jessica Lo Surdo United States	12	221 0.7×	422 1.4×	189 1.0×	122 1.1×	74 0.8×	14	622
Alba Murgia Italy	12	248 0.8×	370 1.2×	229 1.2×	74 0.6×	50 0.5×	17	642
Gerhard Laschober Austria	11	246 0.8×	438 1.5×	248 1.3×	142 1.2×	92 1.0×	16	853
Nastaran Z. Kuhn United States	8	299 1.0×	520 1.7×	218 1.1×	147 1.3×	48 0.5×	11	1.0k
Christopher C. West United Kingdom	11	293 1.0×	322 1.1×	249 1.3×	109 0.9×	89 0.9×	22	819
Sherezade Fuentes‐Julián Spain	8	221 0.7×	383 1.3×	213 1.1×	63 0.5×	39 0.4×	10	751
Anita Laitinen Finland	13	319 1.0×	383 1.3×	267 1.4×	90 0.8×	32 0.3×	21	698
Anne Schellenberg Germany	9	266 0.9×	312 1.0×	180 0.9×	63 0.5×	116 1.2×	9	535
Bithiah Grace Jaganathan India	14	417 1.4×	244 0.8×	149 0.8×	174 1.5×	61 0.6×	32	967
Rachel A. Oldershaw United Kingdom	13	505 1.6×	261 0.9×	298 1.5×	116 1.0×	38 0.4×	30	1.2k

Countries citing papers authored by Brock Reeve

Since Specialization

Citations

This map shows the geographic impact of Brock Reeve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brock Reeve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brock Reeve more than expected).

Fields of papers citing papers by Brock Reeve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brock Reeve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brock Reeve. The network helps show where Brock Reeve may publish in the future.

Co-authorship network of co-authors of Brock Reeve

This figure shows the co-authorship network connecting the top 25 collaborators of Brock Reeve. A scholar is included among the top collaborators of Brock Reeve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brock Reeve. Brock Reeve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Levy, Oren, Rui Kuai, Erika M. J. Siren, et al.. (2020). Shattering barriers toward clinically meaningful MSC therapies. Science Advances. 6(30). eaba6884–eaba6884. 447 indexed citations breakdown →

2.

Ng, Kelvin S., James Smith, Ben Mead, et al.. (2018). Bioprocess decision support tool for scalable manufacture of extracellular vesicles. Biotechnology and Bioengineering. 116(2). 307–319. 31 indexed citations

3.

Davies, Benjamin M., James Smith, Anna French, et al.. (2017). An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol. Systematic Reviews. 6(1). 120–120. 8 indexed citations

4.

Davies, Benjamin M., James Smith, Karolina Wartolowska, et al.. (2017). A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. Journal of Tissue Engineering. 8. 2749453821–2749453821. 12 indexed citations

5.

Caplan, Arnold I., Chris Mason, & Brock Reeve. (2016). The 3Rs of Cell Therapy. Stem Cells Translational Medicine. 6(1). 17–21. 14 indexed citations

6.

Dahéron, Laurence, Richard Barker, Andrew Carr, et al.. (2015). Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies. Cell stem cell. 16(1). 13–17. 46 indexed citations

7.

Wall, Ivan, et al.. (2014). The global intellectual property landscape of induced pluripotent stem cell technologies. Nature Biotechnology. 32(8). 742–748. 33 indexed citations

8.

French, Anna, et al.. (2014). Global strategic partnerships in regenerative medicine. Trends in biotechnology. 32(9). 436–440. 7 indexed citations

9.

Mason, Chris, et al.. (2013). Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment. Cell stem cell. 12(6). 644–647. 14 indexed citations

10.

Brindley, David, Natasha L. Davie, William A. Sahlman, et al.. (2012). Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012. Cell stem cell. 10(5). 492–496. 12 indexed citations

11.

Mason, Chris, et al.. (2012). The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012. Cell stem cell. 11(6). 735–739. 16 indexed citations

12.

Reeve, Brock. (2012). Creative Cross-Organizational Collaboration: Coming to a Project Near you. Regenerative Medicine. 7(2). 237–243. 3 indexed citations

13.

Brindley, David, Brock Reeve, William A. Sahlman, et al.. (2011). The Impact of Market Volatility on the Cell Therapy Industry. Cell stem cell. 9(5). 397–401. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact